Xtl Biopharmaceuticals (XTLB) Operating Income Growth (1y) (2010 - 2024)
Xtl Biopharmaceuticals (XTLB) Operating Income Growth (1y) (2010 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 2,150.96% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 145.20% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Xtl Biopharmaceuticals | 2.60 Bn | 2.60 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -60.53% |
| Sep 30, 2024 | 99.80% |
| Jun 30, 2024 | -373.01% |
| Mar 31, 2024 | 169.72% |
| Dec 31, 2023 | 13.36% |
| Sep 30, 2023 | -11.48% |
| Jun 30, 2023 | 19.31% |
| Mar 31, 2023 | -0.80% |
| Dec 31, 2022 | 13.57% |
| Sep 30, 2022 | -13.59% |
| Jun 30, 2022 | 33.33% |
| Mar 31, 2022 | -7.33% |
| Dec 31, 2021 | -591.05% |
| Sep 30, 2021 | 689.86% |
| Jun 30, 2021 | -39.63% |
| Mar 31, 2021 | -190.27% |
| Dec 31, 2020 | 82.15% |
| Sep 30, 2020 | -121.77% |
| Jun 30, 2020 | -8.50% |
| Mar 31, 2020 | 229.15% |